Current treatments in atrial fibrillation and acute coronary syndrome, safety and guidelines

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Doctor Sneha Jain

Stanford Health Care, Palo Alto (United States of America)

5 More presentations in this session

Presentation thumbnail

Welcome

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Stroke prevention in atrial fibrillation and MACE after acute coronary syndrome: prevalence and challenges

Professor D. Capodanno (Catania, IT)

Presentation thumbnail

Targeting factor XI: innovations in anticoagulation

Doctor J. Weitz (Hamilton, CA)

Presentation thumbnail

Shaping clinical practice and clinical trials

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Audience Q&A and closing remarks

Professor C. Lam (Singapore, SG) Doctor S. Jain (Palo Alto, US) Professor D. Capodanno (Catania, IT) Doctor J. Weitz (Hamilton, CA)

Access the full session

Session thumbnail

Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies

Congress Session

Guidelines in Practice: 2024 ESC Guidelines for the Management of Atrial Fibrillation

Congress Session

Difficult decisions in atrial fibrillation patients: who and how to anticoagulate

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources